# Eric J. Lawitz, M.D. – FDA Inspection, May 14, 2010

Source: https://www.keypedia.com/records/fda_inspections/eric-j-lawitz-md/70d8a856-26c6-40b1-9e85-1bbfd591f5e9
Source feed: FDA_Inspections

> FDA inspection 662046 of Eric J. Lawitz, M.D., May 14, 2010. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 662046
- Company Name: Eric J. Lawitz, M.D.
- Inspection Date: 2010-05-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1227747 - 2024-01-19
- [FDA Inspection 1006414 - 2017-03-03](https://www.keypedia.com/records/fda_inspections/eric-j-lawitz-md/5b8da1ab-02b8-41fb-acb6-70da768c1d0e)
- FDA Inspection 837585 - 2013-06-24
- [FDA Inspection 797771 - 2012-08-24](https://www.keypedia.com/records/fda_inspections/eric-j-lawitz-md/c9ddd703-4ee6-4317-9094-a680af09a7f3)

Company: https://www.keypedia.com/companies/eric-j-lawitz-md/02862e28-6e65-4b53-a9df-0bfa4a44dade

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
